ICCS 2025 - Sponsors and Partners
|
Evotec is a biotechnology company focused on delivering highly effective new therapeutics to patients. The Company leverages its multimodality platforms for proprietary projects and pipeline co-creation with partners including Pharma, Biotech, academics, and other healthcare stakeholders. Our business model is flexible, ranging from service-based support to strategic partnerships.
Evotec offers a fully integrated end-to-end platform to move iPSC-based cell therapy projects from inception to the clinic, including in-house GMP manufacturing capabilities with clinical supply. Our proprietary iPSC-based cell therapy pipeline is one of the broadest in the industry and includes anti-tumor therapies (NK cells, macrophages, αβ T cells, γδ T cells), regenerative therapies (beta cells, cardiomyocytes, photoreceptors) and immune-modulation therapies. In addition, Evotec provides integrated drug development solutions, covering safety assessment, CMC, process and analytical development, regulatory and clinical services for autologous and allogeneic cell therapy candidates. Contact; Bernd Mühlenweg, Senior Vice President, Head of Global Business Development, Cell Therapy |
|
Tunnell Consulting was founded in 1962 during a time of rapid economic expansion. A core group of forward-thinking experts provided consulting services for strategic planning, manufacturing and industrial engineering, and Total Quality Management (TQM) projects. Serving a wide range of clients, from transportation to life sciences, they formed the foundation of what is today’s Tunnell Consulting.
Today, Tunnell’s clients include major global pharmaceutical and biotechnology companies as well as numerous mid-size and emerging life sciences firms. Continued growth has been experienced as a result of Tunnell’s highly esteemed reputation in delivering extraordinary results. |
|
Foley Hoag is a leading international law firm with a primary focus on the life sciences industry. We represent over 2,000 major biotech and pharmaceutical companies, as well as leading investors, academic institutions, and emerging companies throughout the world.
We offer a full range of services, and our international client base includes companies in all stages of development, from startups to Fortune 50 companies. We have substantial experience in all areas of the life sciences industry, including biotechnology, pharmaceuticals, medical devices, and healthcare (including hospitals). By drawing on the talents of a wide variety of professionals, many of whom have had previous careers as scientists and high-ranking government officials, we help companies and investors navigate the complex waters associated with the development, approval, commercialization, reimbursement and coverage of innovative medical products and services. |
|
Precision is the first global precision medicine full service clinical research organization, purpose-built to improve the clinical research and development process for new therapeutics.
Our novel approach integrates clinical operations excellence, along with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients’ insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply our expertise to trials at all stages—from early development through approval—with imbedded experience in oncology and rare disease. With over 2500 people and 35 offices worldwide, we stand ready to help accelerate life-changing treatments anywhere around the globe. |
Organizers:
